document.write('<div id="newsmain"><table class="nftable"><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.phtcorp.com/ target="$targ"  >PHT</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530768&newsfeed_type=cat2&cusid=raucon target=_blank>PHT Corporation Completes Audit of Quality Management System by TUV Rheinland of North America and Discusses Quality in Clinical Trials</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-30 <A HREF=http://www.frx.com/ target="$targ"  >Forest Laboratories</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530698&newsfeed_type=cat2&cusid=raucon target=_blank>Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-27 <A HREF=http://www.emea.eu.int/ target="$targ"  >European Agency for the Evaluation of Medicinal Products (EMEA)</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530713&newsfeed_type=cat2&cusid=raucon target=_blank>European Medicines Agency starts review of Pandemrix</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-27 <A HREF=http://www.ricerca.com/ target="$targ"  >Ricerca Biosciences</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530676&newsfeed_type=cat2&cusid=raucon target=_blank>Ricerca Biosciences Successfully Completes cGMP Prep HPLC Purification</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-27 <A HREF=http://www.roche.com/ target="$targ"  >Roche</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530673&newsfeed_type=cat2&cusid=raucon target=_blank>Roche provides update on FDA application for T-DM1</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-27 <A HREF=http://www.iderapharma.com/ target="$targ"  >Idera Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530655&newsfeed_type=cat2&cusid=raucon target=_blank>Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-27 <A HREF=http://www.iderapharma.com/ target="$targ"  >Idera Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530653&newsfeed_type=cat2&cusid=raucon target=_blank>Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-27 <A HREF=http://www.novartis.com/ target="$targ"  >Novartis</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530320&newsfeed_type=cat2&cusid=raucon target=_blank>Novartis drug Tasigna? approved in Switzerland after fast-track review for treatment of patients with newly diagnosed Ph+ CML</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.alexza.com/ target="$targ"  >Alexza Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530707&newsfeed_type=cat2&cusid=raucon target=_blank>Alexza&#39;s Staccato(R) Nicotine Licensed to Cypress Bioscience</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.ricerca.com/ target="$targ"  >Ricerca Biosciences</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530675&newsfeed_type=cat2&cusid=raucon target=_blank>Ricerca Biosciences Successfully Completes cGMP Prep LC Purification</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.luminexcorp.com/ target="$targ"  >Luminex</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530665&newsfeed_type=cat2&cusid=raucon target=_blank>Luminex Announces Commercial Launch of New Cystic Fibrosis Test</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.prometheuslabs.com/ target="$targ"  >Prometheus Laboratories</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530766&newsfeed_type=cat2&cusid=raucon target=_blank>Prometheus Launches the First Serogenetic Test to Predict Risk of Complications from Crohn&#8217;s Disease</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.vandapharmaceuticals.com/ target="$targ"  >Vanda Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530664&newsfeed_type=cat2&cusid=raucon target=_blank>Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.jnj.com/ target="$targ"  >Johnson & Johnson</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530357&newsfeed_type=cat2&cusid=raucon target=_blank>Johnson&#39;s? Brand Launches Johnson&#39;s? Natural&#8482; Product Line for Babies and Kids Brings Affordable, Natural Products to All Moms at Mass Retail</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.karobio.se/ target="$targ"  >Karo Bio</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530356&newsfeed_type=cat2&cusid=raucon target=_blank>KARO BIO PRESENTS PHASE III CLINICAL TRIALS DESIGN FOR EPROTIROME</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.kingpharm.com/ target="$targ"  >King Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530354&newsfeed_type=cat2&cusid=raucon target=_blank>King Pharmaceuticals Launches CYANOKIT? At Fire-Rescue International Expo</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-26 <A HREF=http://www.xyloscorp.com/content/overview/company_overview.htm target="$targ"  >Xylos</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530328&newsfeed_type=cat2&cusid=raucon target=_blank>XYLOS? CORPORATION AND UNIVERSITY OF MISSISSIPPI MEDICAL CENTER ANNOUNCE FIRST HUMAN IMPLANT OF SECURIAN? TISSUE REINFORCEMENT MATRIX FOR TENDON REPAIR</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=www.gene.com/ target="$targ"  >Genentech</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530659&newsfeed_type=cat2&cusid=raucon target=_blank>Genentech Provides Update on FDA Application for T-DM1</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=http://www.mskcc.org/ target="$targ"  >Memorial Sloan-Kettering Cancer Center</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530325&newsfeed_type=cat2&cusid=raucon target=_blank>New Targeted Therapy For Advanced Melanoma Associated With 80 Percent Response Rate</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=http://www.zymogenetics.com/ target="$targ"  >ZymoGenetics</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530161&newsfeed_type=cat2&cusid=raucon target=_blank>ZymoGenetics Announces Completion of Enrollment in Phase 2b Clinical Trial with PEG-Interferon lambda in Hepatitis C</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=http://www.impaxlabs.com/ target="$targ"  >IMPAX Laboratories</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530121&newsfeed_type=cat2&cusid=raucon target=_blank>Impax Pharmaceuticals Completes Enrollment in ADVANCE-PD Phase III Trial of IPX066 in Parkinson&#39;s Disease</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=http://www.omnicarecr.com/ target="$targ"  >Omnicare Clinical Research</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530110&newsfeed_type=cat2&cusid=raucon target=_blank>Visit Omnicare Clinical Research at Booth 420 at SCDM</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.jnj.com/ target="$targ"  >Johnson & Johnson</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530750&newsfeed_type=cat2&cusid=raucon target=_blank>Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=http://www.molmed.com/ target="$targ"  >MolMed</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530100&newsfeed_type=cat2&cusid=raucon target=_blank>Publication of Phase II trial of NGR-hTNF in colorectal cancer by the European Journal of Cancer</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-25 <A HREF=http://www.neuralstem.com/ target="$targ"  >NeuralStem</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530095&newsfeed_type=cat2&cusid=raucon target=_blank>Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.advancedlifesciences.com/ target="$targ"  >Advanced Life Sciences</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530735&newsfeed_type=cat2&cusid=raucon target=_blank>Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.raptorpharma.com/ target="$targ"  >Raptor Pharmaceutical</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530679&newsfeed_type=cat2&cusid=raucon target=_blank>Raptor Pharmaceutical Provides Financial and Clinical Program Updates</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.jnj.com/ target="$targ"  >Johnson & Johnson</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530359&newsfeed_type=cat2&cusid=raucon target=_blank>BabyCenter? Launches BabyCenter? My Pregnancy Today Application for iPhone? and iPod touch?; 60 Percent of Expectant Moms Want App to Track Pregnancy</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.simulations-plus.com/ target="$targ"  >Simulations Plus</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530183&newsfeed_type=cat2&cusid=raucon target=_blank>Simulations Plus (SLP) Releases GastroPlus(TM) Version 7.0</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.eisai.co.jp/index-e.html target="$targ"  >Eisai</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530027&newsfeed_type=cat2&cusid=raucon target=_blank>EISAI ANNOUNCES POSITIVE RESULTS OF PHASE III TRIAL FOR PERAMPANEL IN EPILEPSY</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.hemispherx.net/ target="$targ"  >Hemispherx BioPharma</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530024&newsfeed_type=cat2&cusid=raucon target=_blank>HEMISPHERX SETTLES ALL SECURITIES CLASS ACTIONS Title</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.kci1.com/ target="$targ"  >Kinetic Concepts</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530021&newsfeed_type=cat2&cusid=raucon target=_blank>New KCI Product Designed to Manage Incisions Following Surgery, Such as General, OB/GYN, Orthopedic, Cardiac Procedures</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.merck.com/ target="$targ"  >Merck & Co</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530015&newsfeed_type=cat2&cusid=raucon target=_blank>New DR. SCHOLL&#39;S? FOR HER Fast Flats&#8482; Offer a Practical Solution For a Long Day or Night in Heels</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.masimo.com/ target="$targ"  >Masimo</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530746&newsfeed_type=cat2&cusid=raucon target=_blank>Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.modigenetech.com/ target="$targ"  >Modigene</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530012&newsfeed_type=cat2&cusid=raucon target=_blank>PROLOR BIOTECH RECEIVES FDA CLEARANCE FOR A PHASE II TRIAL OF ITS LONG-ACTING HUMAN GROWTH HORMONE IN THE U.S.</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-24 <A HREF=http://www.syntapharma.com/ target="$targ"  >Synta Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530010&newsfeed_type=cat2&cusid=raucon target=_blank>Synta Announces First Patient Treated in Clinical Trial of STA-9090 in Combination with Docetaxel in Solid Tumors</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.pfizer.com/main.html target="$targ"  >Pfizer</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530214&newsfeed_type=cat2&cusid=raucon target=_blank>Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.hanmipharm.com/ target="$targ"  >Hanmi Pharmaceutical Company</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530125&newsfeed_type=cat2&cusid=raucon target=_blank>Hanmi initiates the clinical trials of Amosartan in Europe</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.labcorp.com/ target="$targ"  >Laboratory Corporation of America</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530020&newsfeed_type=cat2&cusid=raucon target=_blank>LabCorp Enhances HCV Testing Services with the Launch of IL-28B Test</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.genzyme.com/ target="$targ"  >Genzyme</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529978&newsfeed_type=cat2&cusid=raucon target=_blank>Two-Year Data from Phase 2 Trial of Genzyme&#8217;s Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal Blood</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.gsk.com/ target="$targ"  >GlaxoSmithKline</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529977&newsfeed_type=cat2&cusid=raucon target=_blank>GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.insitevision.com/ target="$targ"  >InSite Vision</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529976&newsfeed_type=cat2&cusid=raucon target=_blank>InSite Vision Commences Phase 1/2 Clinical Study of ISV-303 for Post-Surgical Ocular Pain and Swelling</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-23 <A HREF=http://www.mannkindcorp.com/ target="$targ"  >MannKind</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529969&newsfeed_type=cat2&cusid=raucon target=_blank>MannKind Corporation Providing AFREZZA(TM) to Juvenile Diabetes Research Foundation for Artificial Pancreas Project</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-20 <A HREF=http://www.angeion.com/ target="$targ"  >Angeion</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529930&newsfeed_type=cat2&cusid=raucon target=_blank>Angeion and Data Innovations Partner to Create New MedGraphics BreezeConnect&#8482;</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.mdsol.com/ target="$targ"  >Medidata Solutions</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530743&newsfeed_type=cat2&cusid=raucon target=_blank>PharmaNet Joins Medidata Solutions&#8217; CRO Partner Program</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-19 <A HREF=http://www.mannkindcorp.com/ target="$targ"  >MannKind</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529971&newsfeed_type=cat2&cusid=raucon target=_blank>MannKind Announces Pricing of $100 Million Senior Convertible Notes</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-19 <A HREF=http://www.gidynamics.com/ target="$targ"  >GI Dynamics</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529928&newsfeed_type=cat2&cusid=raucon target=_blank>GI Dynamics Announces Key Executive Appointments in Preparation for European Launch of EndoBarrier(TM) Gastrointestinal Liner</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-19 <A HREF=http://www.hanger.com/ target="$targ"  >Hanger Orthopedic Group</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529925&newsfeed_type=cat2&cusid=raucon target=_blank>Hanger Orthopedic Group Launches &#39;ARTroduction to Austin&#39;</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-19 <A HREF=http://www.bioniche.com/ target="$targ"  >Bioniche Life Sciences</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529922&newsfeed_type=cat2&cusid=raucon target=_blank>Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-19 <A HREF=www.oxis.com target="$targ"  >OXIS International</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529909&newsfeed_type=cat2&cusid=raucon target=_blank>OXIS International, Inc. (OXIS) Announces Publication of Positive Results of Ergothioneine Safety Study in the Journal &#39;TOXICOLOGY&#39;</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-18 <A HREF=http://www.mindray.com/main/index.jsp target="$targ"  >Mindray Medical International</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530089&newsfeed_type=cat2&cusid=raucon target=_blank>Mindray Launches New Premium M7 Portable Ultrasound System in U.S.</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-18 <A HREF=http://www.quarkbiotech.com/ target="$targ"  >Quark Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529957&newsfeed_type=cat2&cusid=raucon target=_blank>Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-18 <A HREF=http://www.reprosrx.com/ target="$targ"  >Repros Therapeutics</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529226&newsfeed_type=cat2&cusid=raucon target=_blank>Repros Requests Type B Meeting with FDA to Discuss Phase III Protocols for Androxal</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-17 <A HREF=http://www.lilly.com/ target="$targ"  >Eli Lilly</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529588&newsfeed_type=cat2&cusid=raucon target=_blank>Lilly Halts Development of Semagacestat for Alzheimer&#39;s Disease Based on Preliminary Results of Phase III Clinical Trials</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-17 <A HREF=http://www.armagen.com/ target="$targ"  >ArmaGen Technologies</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529308&newsfeed_type=cat2&cusid=raucon target=_blank>ArmaGen completes Pre-IND Meeting with FDA for AGT-181</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.schering.de/ target="$targ"  >Bayer Schering Pharma</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530731&newsfeed_type=cat2&cusid=raucon target=_blank>Bayer?s Rivaroxaban Successfully Meets Primary Efficacy Outcome and Demonstrates Similar Safety to Standard Therapy in Phase III EINSTEIN-DVT Non-Inferiority Study</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-17 <A HREF=http://www.xenon-pharma.com/ target="$targ"  >Xenon Pharmaceuticals</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529036&newsfeed_type=cat2&cusid=raucon target=_blank>Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-17 <A HREF=http://www.luminexcorp.com/ target="$targ"  >Luminex</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529022&newsfeed_type=cat2&cusid=raucon target=_blank>Luminex Donates Company&#39;s First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.morphotek.com/ target="$targ"  >Morphotek</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529888&newsfeed_type=cat2&cusid=raucon target=_blank>Morphotek, Inc. Announces Initiation of A Phase I Study for MORAb-028, an IgM-Type Monoclonal Antibody, in Patients with Advanced Melanoma</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.dow.com/ target="$targ"  >Dow Chemical Company</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529503&newsfeed_type=cat2&cusid=raucon target=_blank>Dow Announces Divisional Structure and Leadership Changes to Drive Next Phase of Transformation</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.orthofix.com/ target="$targ"  >Orthofix International</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529285&newsfeed_type=cat2&cusid=raucon target=_blank>Orthofix International Introduces FUSION(R) XT High Performance Knee Brace with New AirTech(TM) Innovation</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.agion-tech.com/ target="$targ"  >Agion Technologies</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529206&newsfeed_type=cat2&cusid=raucon target=_blank>Verdes Toys Teams Up with Agion to Launch ColorWood Foam Building Blocks for Toddlers, Available at National Retail Chains</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.bayercropscience.com/ target="$targ"  >Bayer CropScience</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=529052&newsfeed_type=cat2&cusid=raucon target=_blank>Bayer CropScience plans to discontinue Aldicarb by 2014</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.starpharma.com/ target="$targ"  >Starpharma Group</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=528931&newsfeed_type=cat2&cusid=raucon target=_blank>Starpharma Commences Phase 2 Bacterial Vaginosis Study of VivaGel?</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.mesoblast.com/ target="$targ"  >Mesoblast</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=528901&newsfeed_type=cat2&cusid=raucon target=_blank>MESOBLAST ON TRACK FOR PHASE 3 BONE MARROW TRANSPLANT TRIAL FOLLOWING POSITIVE MEETING WITH FDA</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-16 <A HREF=http://www.capario.com/ target="$targ"  >Capario</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=528886&newsfeed_type=cat2&cusid=raucon target=_blank>Capario Releases Significant Update to its Revenue Cycle Management Portal Application</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-31 <A HREF=http://www.molmed.com/ target="$targ"  >MolMed</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530729&newsfeed_type=cat2&cusid=raucon target=_blank>Publication of Phase II trial results of NGR-hTNF in liver cancer by the British Journal of Cancer</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-30 <A HREF=http://www.intendis.com/ target="$targ"  >Intendis</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530754&newsfeed_type=cat2&cusid=raucon target=_blank>Intendis and KYTHERA Enter Licensing and Development Agreement on Adipolytic Agent for Aesthetic Dermatology Use</A></TD></TR><tr class="nfsubhead"><TD> 2010-08-30 <A HREF=http://www.scibase.se/ target="$targ"  >SciBase</A></TD></TR><tr class="nfsummary"><td class="nftd"><p class="nf"> <A HREF=newsfeed_news.htm?releaseid=530706&newsfeed_type=cat2&cusid=raucon target=_blank>SciBase successfully achieves clinical study objectives</A></TD></TR></TABLE></DIV>');